52 North Health
52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.
52 North Health is active in the artificial intelligence (ai), health care, medical space based in Europe, Middle East, and Africa (EMEA), founded in 2018.
Within the artificial intelligence (ai), health care, medical space, the company focuses on its core offering rather than a broad product line.
The business is associated with Europe, Middle East, and Africa (EMEA).
The company is listed at the Non_Equity_Assistance stage of development.
Its team size is recorded as c_00011_00050 employees.
Public records show total funding of about $3.4M.
| Sector | Artificial Intelligence (AI), Health Care, Medical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Country | GB |
| Founded | 2018 |
| Employees | c_00011_00050 |
| Stage | non_equity_assistance |
| Total funding | $3,400,000 |
Website: www.52north.health
Browse related
Sign in to view the contact information we hold for 52 North Health.
Create a free account
Create a free account